Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | CuttingEdgeInfo Reports | Oncology Market Forecast to 2013 (TA220)

Oncology Market Forecast to 2013 (TA220)

Give Your Team Access to the Most Comprehensive Oncology Forecast Ever Created

Cutting Edge Information's new report, "Oncology Market Forecast to 2013," explores the fiercely competitive oncology market in a way that no other available forecast can match.

Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever - pulling together data from our own proprietary PharmaEdge databases, along with hundreds of additional public and private databases worldwide.

Give your brand team all the oncology data it needs to make critical product decisions!

Key Questions This Report Will Answer:

Which drugs will make the most money in the next five years?

Which drug classes are poised for exponential growth?

Whose portfolio will allow them to jump out in front of the oncology market?

The report profiles more than 130 Oncology Products and includes Oncology Portfolio Profiles for the following major companies:

Amgen

AstraZeneca

Bristol-Myers Squibb

Celgene

Eli Lilly

GlaxoSmithKline

ImClone

Johnson & Johnson

Merck

Novartis

Pfizer

Roche

Sanofi-Aventis

Schering-Plough

130+ Oncology Products

14 Company Portfolio Profiles

1000+ Metrics

900+ Charts and Diagrams
Table of Contents
Price: $9,995.00 / €6,686.66

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions